Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

RPEP-030402016Marso, Steven P; Daniels, Gilbert H; Brown-Frandsen, Kirstine; Kristensen, Peter; Mann, Johannes F E; Nauck, Michael A; Nissen, Steven E; Pocock, Stuart; Poulter, Neil R; Ravn, Lasse S; Steinberg, William M; Stockner, Mette; Zinman, Bernard; Bergenstal, Richard M; Buse, John B

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

The New England journal of medicine, 375(4), 311-22

View on PubMed ↗Publisher’s paper ↗

Citation

Marso, Steven P; Daniels, Gilbert H; Brown-Frandsen, Kirstine; Kristensen, Peter; Mann, Johannes F E; Nauck, Michael A; Nissen, Steven E; Pocock, Stuart; Poulter, Neil R; Ravn, Lasse S; Steinberg, William M; Stockner, Mette; Zinman, Bernard; Bergenstal, Richard M; Buse, John B. (2016). Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.. The New England journal of medicine, 375(4), 311-22. https://doi.org/10.1056/NEJMoa1603827